<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare the effects of a novel soy germ-enriched pasta, containing <z:chebi fb="0" ids="18220">isoflavone</z:chebi> aglycons, with conventional pasta on endothelial function and cardiovascular risk markers in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2D) </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: This randomized controlled double-blind crossover study compared one serving/day of soy germ pasta and conventional pasta for 8 weeks for effects on brachial artery flow-mediated vasodilation, blood pressure, plasma <z:chebi fb="23" ids="18059">lipids</z:chebi>, oxidized <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, 8-iso-PGF2α, total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity (<z:chebi fb="44" ids="53498">TAC</z:chebi>), <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:chebi fb="0" ids="18220">Isoflavone</z:chebi>-enriched pasta significantly improved arterial stiffness (P = 0.005) and reduced systolic (P = 0.026) and diastolic (P = 0.017) blood pressures </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma <z:chebi fb="44" ids="53498">TAC</z:chebi> increased (P = 0.0002), oxidized <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> decreased (P = 0.009), 8-iso-PGF2α decreased (P = 0.001), GSH levels increased (P = 0.0003), and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> decreased (P = 0.009) consistent with a reduction in <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>No significant changes were observed with conventional pasta </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: Pasta enriched with biologically active <z:chebi fb="0" ids="18220">isoflavone</z:chebi> aglycons improved endothelial function and had beneficial effects on cardiovascular risk markers in patients with T2D </plain></SENT>
</text></document>